Dermavant Sciences Inc, 2102 E State Highway 114, Ste 2-217, Southlake, TX 76092, US

OncoNano Medicine, Inc. is a biotechnology company based in Southlake, Texas, specializing in the development of innovative products for the diagnosis and treatment of cancer. Their cutting-edge technology utilizes ultra pH-sensitive polymeric micelles to encapsulate and selectively release therapeutic and imaging payloads in acidic tumor microenvironments, enabling targeted delivery while minimizing exposure to normal tissues. With a focus on exploiting universal tumor and immune targets, OncoNano Medicine aims to provide patients with a range of solutions, including solid tumor therapeutics, real-time image-guided surgery agents, and T cell activating immunotherapies. Through their proprietary micelle technology, OncoNano Medicine has achieved threshold pH sensing and activation of Stimulator of Interferon Genes (STING), a crucial immune signaling molecule for T cell therapy of solid tumors. This unique approach allows for high specificity in tumor targeting and has shown promising results in preclinical studies and in patients. With a well-funded company and strategic partnerships, OncoNano Medicine is at the forefront of advancing cancer identification and treatment, making meaningful impacts across the continuum of patient care.Generated from the website

Phelps Dunbar LLP

Janszen Charitable Trust

Form Yps

Slalom